MEI Pharma Inc. has become the first U.S.-listed public company to adopt litecoin ( LTC) as a primary reserve asset, deploying $100 million from a recent stock sale to acquire 929,548 tokens of the cryptocurrency. Litecoin Creator Charlie Lee Joins MEI Pharma’s Board The clinical-stage biopharmaceutical company (Nasdaq: MEIP) disclosed the LTC acquisition in an […]
Source link
